Lam Research stock holds near highs after Susquehanna lifts LRCX target to $250
12 January 2026
1 min read

Lam Research stock holds near highs after Susquehanna lifts LRCX target to $250

New York, Jan 12, 2026, 10:25 (EST) — Regular session underway

  • Shares of Lam Research ticked up following Susquehanna’s boost to its price target.
  • Chip-tool stocks showed a mixed picture as Wall Street dipped amid worries over Fed independence.
  • Attention now turns to Lam’s late-January results for clues on chip-factory investment and its China exposure.

Lam Research shares inched up 0.3% to $219.05 on Monday after Susquehanna lifted its price target for the chip-equipment giant to $250, maintaining a Positive rating. Analyst Mehdi Hosseini cited channel checks indicating the industry is gearing up for roughly $120 billion in wafer-fab equipment spending, with projections exceeding $150 billion over the longer term. 1

Timing is crucial. Investors are returning to semiconductor capital equipment—the expensive machinery chipmakers snap up to grow their fabs—betting that AI data centers are accelerating demand.

Wall Street’s major indexes kicked off lower amid fresh doubts about the Federal Reserve’s independence, stirring volatility in rate-sensitive tech stocks. The market is clearly unsettled. 2

Bernstein analyst Stacy Rasgon said the firm finds “little reason to change our broad perspective,” sticking with companies it views as best placed for long-term AI investment. The firm plans to “own semicap even as valuations reach nosebleed levels,” maintaining Outperform ratings on Lam Research and Applied Materials. 3

Applied Materials climbed around 2%, and KLA added about 0.6%, but Dutch chip-equipment maker ASML dipped a bit. A semiconductor ETF tracking the sector saw little movement.

Lam, headquartered in Fremont, California, provides tools for etching, deposition, and cleaning—key processes chipmakers ramp up spending on as they move to smaller, more intricate designs. Its earnings also fluctuate with memory cycles, since customers typically slash spending quickly when prices drop.

The broader industry remains focused on hefty figures. In December, SEMI, an industry group, projected global chipmaking equipment sales to jump around 9% to $126 billion in 2026, then rise another 7.3% in 2027 as chipmakers ramp up capacity for AI-focused logic and memory. 4

The risk here is blunt. Reuters revealed late last month that China now demands chipmakers use at least 50% domestically produced equipment when expanding capacity. This mandate could pressure foreign suppliers, even if tools remain accessible. 5

Lam’s shares entered this week on a strong note, soaring 8.7% Friday after Mizuho bumped its price target up to $220 from $200. 6

Lam’s next major event is its quarterly earnings call on Jan. 28, scheduled for after the market close. Investors will focus on 2026 spending outlooks and watch closely for hints about China’s demand and any regulatory impacts. 7

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Netflix stock rises as Paramount lawsuit turns up heat on Warner deal, HSBC starts with Buy
Previous Story

Netflix stock rises as Paramount lawsuit turns up heat on Warner deal, HSBC starts with Buy

Vistra stock rises as VST launches secured notes sale to help fund Cogentrix dealIRVING,
Next Story

Vistra stock rises as VST launches secured notes sale to help fund Cogentrix dealIRVING,

Go toTop